SEER/Medicare (Surveillance Epidemiology and End Results) study included 73,196 men over 66 years old who were diagnosed with locoregional prostate cancer between 1992 to 1999 and observed through 2001, treated with orchiectomy associated or not with GnRH agonist. The gene discussed is GNRH1; the disease is prostate cancer.